发明名称 Hepatitis C inhibitor tri-peptides
摘要 Racemates, diastereoisomers and optical isomers of a compound of formula (I):whereinB is H, a C6 or C10 aryl, C7-16 aralkyl; Het or (lower alkyl)-Het, all of which optionally substituted with C1-6 alkyl; C1-6 alkoxy; C1-6 alkanoyl; hydroxy; hydroxyalkyl; halo; haloalkyl; nitro; cyano; cyanoalkyl; amino optionally substituted with C1-6 alkyl; amido; or (lower alkyl)amide; orB is an acyl derivative of formula R4-C(O)-; a carboxyl of formula R4-O-C(O)-; an amide of formula R4-N(R5)-C(O)-; a thioamide of formula R4-N(R5)-C(S)-; or a sulfonyl of formula R4-SO2; R5 is H or C1-6 alkyl; andY is H or C1-6 alkyl;R3 is C1-8 alkyl, C3-7 cycloalkyl, or C4-10 alkylcycloalkyl, all optionally substituted with hydroxy, C1-6 alkoxy, C1-6 thioalkyl, amido, (lower alkyl)amido, C6 or C10 aryl, or C7-16 aralkyl;R2 is CH2-R20, NH-R20, O-R20 or S-R20, wherein R20 is a saturated or unsaturated C3-7 cycloalkyl or C4-10 (alkylcycloalkyl), all of which being optionally mono-, di- or tri-substituted with R21,or R20 is a C6 or C10 aryl or C7-14 aralkyl optionally substituted, or R20 is Het or (lower alkyl)-Het, both optionally substituted, Het or (lower alkyl)-Het; carboxyl; carboxy(lower alkyl); C6 or C10 aryl, C7-14 aralkyl or Het, said aryl, aralkyl or Het being optionally substituted; andR1 is H; C1-6 alkyl, C3-7 cycloalkyl, C2-6 alkenyl, or C26 alkynyl, all optionally substituted with halogen; or a pharmaceutically acceptable salt or ester thereof.
申请公布号 US6410531(B1) 申请公布日期 2002.06.25
申请号 US20010849057 申请日期 2001.05.04
申请人 BOEHRINGER INGELHEIM (CANADA) LTD. 发明人 LLINAS-BRUNET MONTSE;BAILEY MURRAY D.;CAMERON DALE R.;GHIRO ELISE;GOUDREAU NATHALIE;POUPART MARC-ANDRE;RANCOURT JEAN;TSANTRIZOS YOULA S.;FAUCHER ANNE-MARIE;HALMOS TEDDY;WERNIC DOMINIK M.
分类号 C12N15/09;A61K31/13;A61K31/7056;A61K38/00;A61K38/06;A61K38/21;A61P1/16;A61P31/12;A61P31/14;C07C229/48;C07K1/06;C07K5/08;C07K5/083;C07K5/087;C12N9/50;C12N9/99;C12P21/02;C12P41/00;(IPC1-7):A61K3/535;A61K31/47;C07D413/00;C07D215/16;C07D401/00 主分类号 C12N15/09
代理机构 代理人
主权项
地址